💨 Abstract

Hester Biosciences reported a 36% increase in consolidated net profit to Rs 28.83 crore for FY25, driven by strong growth in poultry healthcare products. Revenue from operations rose to Rs 311.10 crore. Poultry and animal healthcare divisions saw 16% and 6% revenue growth, respectively.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io